| Symposium ENGLISH |
Robotic-assisted gastrectomy has been rapidly introduced, but the distinction between this technique and conventional laparoscopic gastrectomy is not clear. Recently, a new approach combining laparoscopic and robotic surgery has been proposed. In this session, we would like to discuss the differences in the use of robot-assisted gastrectomy and laparoscopic gastrectomy, the fusion approach, and other indications and future perspectives at each institution.
In Japan, all colorectal cancers can be treated with a robot under insurance cover, and robot-assisted surgery is becoming more common for colon cancer. We are also can choose between laparoscopic surgery and robot-assisted surgery. At present, robot-assisted surgery is not yet possible for all cases, and it is necessary to select appropriate options that balance between laparoscopic and robot-assisted surgery. Please show the selection criteria for selection of laparoscopic and robot-assisted surgery, and opetative outcomes.
Seven years have passed since robot-assisted surgery for the treatment of colorectal cancer was covered by the insurance in Japan. Since then, short-term and long-term results have become available. We would like to welcome a presentation on the current issues and future prospects of robotic colorectal surgery.
The publication of guidelines for the management of acute cholangitis and cholecystitis in 2005 marked a significant change in the treatment of acute cholecystitis, leading to better outcomes with medical development. However, cholecystectomy for severe acute cholecystitis carries a high risk of serious complications due to the general condition and age of the patients, resulting in potential differences in treatment selection criteria among institutions. In this session, we would like to present the treatment outcomes for severe acute cholecystitis from various institutions and discuss surgical treatment strategies tailored to an ageing society.
Many elderly patients have multiple comorbidities and frailty (physical, mental and social vulnerability). The indication for high-risk hepatobiliary and pancreatic cancer surgery should not be determined solely by age, and careful patient selection is key to achieving good outcome. Additionally, pre- and post-operative chemotherapy is often required in many diseases, making the maintenance of ADL and QOL during the perioperative period crucial. We would like to discuss the key points of hepatobiliary and pancreatic surgery and perioperative management of elderly and frail patients from different perspectives, including objective assessment of surgical tolerance, means of preoperative intervention and the introduction of minimally invasive surgery.
|
|---|
| Panel Discussion ENGLISH |
There have been positive reports on preoperative chemotherapy for esophagogastric junction cancer. The molecular characteristics of this cancer, as well as its sensitivity to anticancer drugs, molecular-targeted therapies, and immune checkpoint inhibitors, are gradually being clarified. Please discuss treatment strategies by addressing unresolved issues, including the indications for effective multidisciplinary treatment, treatment regimens, the need for radiation, assessment of treatment efficacy, the timing of surgery, and the extent of resection, based on the latest research findings.
The number of elderly patients with gastric cancer is on the increase, and opportunities for treating patients with serious comorbidities are increasing. On the other hand, the risk of death from other diseases is high even when gastric cancer is cured in elderly patients, and they often choose non-standard treatment such as local resection or limited surgery. We would like to discuss treatment strategies for high-risk patients by presenting the results of non-standard treatment (including follow-up cases after non-surgical resection of ESD) for patients with high-risk disease or refusal of surgery.
|
|---|
| Workshop ENGLISH |
Weight loss after gastric cancer surgery affects treatment outcomes, and perioperative nutritional therapy is being studied. Emphasis has been placed on improving adherence to nutritional supplements and offering continuous guidance, with increasing attention on exercise. Positive results from preoperative chemotherapy and conversion surgery for advanced gastric cancer highlight the need for supportive care during treatment. We would like to discuss the strategies and outcomes of nutritional and exercise therapies at different facilities, aiming to enhance patient outcomes.
|
|---|